IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis
Clinical trial NCT03757234 · COMPLETED
Trial details
- NCT number
- NCT03757234
- Sponsor
- Paratek Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-19
- Primary completion
- 2019-06-26
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.